Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Chien

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Plos One|February 21, 2012
Highly parallel genome-wide expression analysis of single mammalian cellsJian-Bing Fan, Jing Chen, Craig S April, et al.
Science (New York, N.Y.)|October 21, 2006
A variant of the HTRA1 gene increases susceptibility to age-related macular degenerationZhenglin Yang, Nicola J Camp, Hui Sun, et al.
Oncotarget|April 2, 2016
The degree of intratumor mutational heterogeneity varies by primary tumor sub-siteLevi G Ledgerwood, Dhruv Kumar, Agda Karina Eterovic, et al.
Cancer Research|April 15, 2014
Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancerChen Wang, Mine S Cicek, Bridget Charbonneau, et al.
Cancer & Metabolism|September 17, 2014
Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancerDebarshi Roy, Susmita Mondal, Chen Wang, et al.
Cancer & Metabolism|June 16, 2015
Erratum to: Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancerDebarshi Roy, Susmita Mondal, Chen Wang, et al.
Breast Cancer Research : BCR|September 19, 2015
Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasionHanan S Elsarraj, Yan Hong, Kelli E Valdez, et al.
Journal of the American Society of Nephrology : JASN|May 6, 2021
Serine Protease HTRA1 as a Novel Target Antigen in Primary Membranous NephropathyLaith Farah Al-Rabadi, Tiffany Caza, Claire Trivin-Avillach, et al.
Human Molecular Genetics|April 11, 2013
Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channelMine S Cicek, Devin C Koestler, Brooke L Fridley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2017
Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular SubtypesStefan Kommoss, Boris Winterhoff, Ann L Oberg, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Plos One|February 21, 2012
Highly parallel genome-wide expression analysis of single mammalian cellsJian-Bing Fan, Jing Chen, Craig S April, et al.
Science (New York, N.Y.)|October 21, 2006
A variant of the HTRA1 gene increases susceptibility to age-related macular degenerationZhenglin Yang, Nicola J Camp, Hui Sun, et al.
Oncotarget|April 2, 2016
The degree of intratumor mutational heterogeneity varies by primary tumor sub-siteLevi G Ledgerwood, Dhruv Kumar, Agda Karina Eterovic, et al.
Cancer Research|April 15, 2014
Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancerChen Wang, Mine S Cicek, Bridget Charbonneau, et al.
Cancer & Metabolism|September 17, 2014
Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancerDebarshi Roy, Susmita Mondal, Chen Wang, et al.
Cancer & Metabolism|June 16, 2015
Erratum to: Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancerDebarshi Roy, Susmita Mondal, Chen Wang, et al.
Breast Cancer Research : BCR|September 19, 2015
Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasionHanan S Elsarraj, Yan Hong, Kelli E Valdez, et al.
Journal of the American Society of Nephrology : JASN|May 6, 2021
Serine Protease HTRA1 as a Novel Target Antigen in Primary Membranous NephropathyLaith Farah Al-Rabadi, Tiffany Caza, Claire Trivin-Avillach, et al.
Human Molecular Genetics|April 11, 2013
Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channelMine S Cicek, Devin C Koestler, Brooke L Fridley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2017
Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular SubtypesStefan Kommoss, Boris Winterhoff, Ann L Oberg, et al.
Pageof 10